Morgan Stanley’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.9M Buy
1,477,488
+55,694
+4% +$775K ﹤0.01% 2553
2025
Q4
$12.6M Buy
1,421,794
+1,170,001
+465% +$10.1M ﹤0.01% 3395
2025
Q3
$2.12M Sell
251,793
-282,828
-53% -$1.91M ﹤0.01% 4741
2025
Q2
$2.74M Buy
534,621
+284,102
+113% +$702K ﹤0.01% 4508
2025
Q1
$343K Sell
250,519
-69,551
-22% -$171K ﹤0.01% 5505
2024
Q4
$989K Sell
320,070
-21,907
-6% -$102K ﹤0.01% 5095
2024
Q3
$2.63M Buy
341,977
+98,608
+41% +$941K ﹤0.01% 4458
2024
Q2
$2.09M Buy
243,369
+63,850
+36% +$493K ﹤0.01% 4535
2024
Q1
$1.43M Sell
179,519
-107,295
-37% -$1.15M ﹤0.01% 4769
2023
Q4
$2.84M Buy
286,814
+93,490
+48% +$812K ﹤0.01% 4742
2023
Q3
$2.18M Buy
193,324
+139,130
+257% +$848K ﹤0.01% 4344
2023
Q2
$180K Sell
54,194
-21,397
-28% -$77K ﹤0.01% 5691
2023
Q1
$299K Buy
75,591
+46,672
+161% +$271K ﹤0.01% 5517
2022
Q4
$210K Buy
28,919
+5,753
+25% +$40.5K ﹤0.01% 5652
2022
Q3
$83K Buy
23,166
+4,734
+26% +$20.2K ﹤0.01% 6175
2022
Q2
$84K Buy
18,432
+2,717
+17% +$16.5K ﹤0.01% 6365
2022
Q1
$119K Buy
15,715
+6,878
+78% +$59.6K ﹤0.01% 6218
2021
Q4
$96K Buy
8,837
+6,990
+378% +$84.1K ﹤0.01% 6468
2021
Q3
$24K Buy
+1,847
New +$22.1K ﹤0.01% 7039

Other funds holding TNGX